Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonquek for Stem Cell Mobilization in MM and Lymphoma
NCT02488382Phase 2Unknown
- Sponsor
- Sheba Medical Center
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Modality
- Cytokines & Interferons, Carrier/Scaffold Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of lipegfilgrastim in multiple myeloma (MM), lymphoma, sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
lipegfilgrastim
03
Conditions
multiple myeloma (MM)lymphoma
Beyond the preview
Go deeper on NCT02488382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02488382.